Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You can say the same about any stock. Just because it spikes doesn't mean you should buy at the high. That's just good investing acumen. Like the S&P 500 right now. I'm not in a hurry to go long any S&P stocks right now because we're at the highs and need to cool off.
Exactly. The OS is extremely low here.
The bottom line is they back up any capital raises with increased revenues. Typically with many companies you'd get capital raise without the revenues to back it up. But the bottom line is the capital has been used for expansion which is already paying for itself. They've proven that you really can make it from the OTC by focusing on the shareholder and being responsible with any funding.
I'll play along too. Progressive Care will report over 600 million in sales for the 1st half 2020. They will buy back all shares leaving just the commons current shareholders hold.
#1 I'm not selling today or next month or the month after. PPS doesn't mean anything right now. It's not meaningful until it reaches my goal.
#2 The PPS was much lower when CV started. So how then could we raise all the capital we did yet the share price is higher?
A couple of reasons for that. One is they have volume restrictions in place and #2 investors still believe in the thesis and know capital raises can only better their investment in the long term.
The only argument that ever comes up is about the PPS being lower than .26 cents. But no one ever talks about the long term curve and PPS appreciation because it's not convenient.
PPS is only a result of low volume OTC. That is the case for EVERY OTC stock that ever existed.
You will not see this act like a big board stock RIGHT NOW because there isn't as much exposure. It's as simple as that. The pay day comes when they uplist and can prove to wallstreet their profitability. But the time to GET IN is now before that happens. By the time they get on Nasdaq the secret about this gem will be out and institutions will have already bought in big time. The time to get in is before that occurs.
I hope the PPS goes down to subs again if you want me to be honest. I want to load the boat even more.
It's not meaningful because the PPS isn't being affected by bearish material news. There is none.
So the risk is 0. All good news and all things going to plan like the company said they would. They have credibility and that's all that counts.
When 99% of OTC have no revenues and a bloated BILLION level # of OUTSTANDING shares, I'd say RXMD is doing EXCELLENT.
The whole point of being public this early on the OTC is to utilize the market in an efficient manner to help with capital expansion.
We've grown the share price from low level subs AND at the same time raised capital.
So CV doesn't mean anything because they've proven not to effect the share price like everyone thinks they will.
It's already been proven that they have no material effect.
And besides, what we get from CV is capital for M&A which is already paying for itself with the added revenues.
So no, CV doesn't affect anything and won't.
We're close to uplisting which means traditional financing anyways.
Good morning all - Should be another solid day for RXMD. Remember that the conference call is November 14th. That's still 4 days of ER run-up that will happen in my opinion. This has legs to go past .10 cents especially with the amount of accumulation the longs have had for years. Most shares are locked up by longs. That's a fact. Very small OS and the shares are in good hands. The company only does capital raises for M&A not for anything else. A mini step back yields 10 steps forward. The business plan has been all about allocating cash and capital where needed, and in an efficient manner so as to not disrupt the overall long term trend of the stock. The word dilution should not be used. This is capital for expansion and it's already paying off. The company is not shy either to paying off the small debt with some cash. It's a very well run and well oiled company. Stellar management.
Are you selling this minute or do you believe in the long term thesis? If the latter then who cares about the RSI. This is a long stock only. No one cares about day to day.
Hello .04s
RXMD looks excellent today! Walgreens and CVS are jealous of this business model. Their model doesn't work anymore. They're closing stores. But with Progressive Care our model is continuing to work with new expansion and no sight of any growth slowdown. All good here. Maybe it will be the next fortune 500.
It's called low volume on the OTC. The stock trend hasn't had anything to do with company fundamentals or capital raise. Simply how the OTC works.
This company will be on CNBC before you know it. Huge money to come in.
Only about $4,000 on the ask until .06. Very thin!
Yup! They are thriving literally right next door to Walgreens and CVS. Customers are starting to get smart to the fact that RXMD is a different kind of service. A more focused healthcare service. They are a 1000 steps ahead of CVS and Walgreens. This is a healthcare services and tech company.
A company gains credibility through exposure. So indirectly more shareholders is better for their business. The only shares added to the mix in RXMD has been for capital expansion. Not to line anyone's pockets.
The promotion isn't promoting things that are false. That's the key difference. They are promoting their great numbers. Similar to an analyst.
The difference between other OTC stocks is the core business. Promotion is good. That name gets a bad rap because it is associated with companies who lie. Progressive Care isn't lying.
And yes with low exposure on the OTC these companies depend on exposure. It makes perfect sense.
If you like that you'll like how responsible they have been with capital for expansion. Very minimal increases to OS to accommodate capital for M&A activities. No share scam here. Simply a strong business. A diamond in the rough if you will.
No insiders have sold any shares. They would have to disclose that information. There's also no reason to sell shares when it's at an historical low compared to the revenue they bring in. So from an investment perspective it wouldn't make sense even if they were. But of course the facts say no selling at all. And the reason is because they know this is going much much higher.
All revenue has been fully audited. The company has done everything they said they would. 100% credibility in my book.
Good morning smart money. RXMD is at an obvious bottom where we could see some nice returns going into 2020. If there was ever a time to buy in it's now. Historical extreme divergence from both valuation and growth as well as accumulation. Simply a share price depressed by lack of exposure. That is starting to come back as people recognize how much of a value play this is.
The facts stand for themselves. High growth, bullish M&A, cash flow positive by Q1, uplisting, etc.
Balance sheet is excellent.
Very normal and standard to try to gain exposure for your company and stock. Nothing wrong with it at all. What matters is if their core business is doing well. Which it is. So they want to promote their growing company? Awesome! This is great to see.
A/D line has been positive meaning accumulation has been increasing not decreasing. Volume is low and there hasn't been any bear news whatsoever. This is simply a great company at the mercy of low volume OTC. This is a short term scenario. Long term share price will appreciate once they can uplist and get more attention.
In terms of profitability it is very standard as a GROWING company to go after growth FIRST. This is common for growth companies. I can name thousands of companies who turn no profit in their early years, expanded through M&A and over the long term became profitable through synergies in the M&A they do.
Revenue is absolutely key and has grown big time over the years. They are already starting to see the fruits of these seeds planted.
Scripts counts have exploded which is a key metric they look at.
Look at the 4 year long term trend chart. We always bounce off of this long term curve. About every year and a half. That next move up would be around the new year time frame.
My guess is the price may come down a little more not breaking .02s for a bottom in December.
Then in 2020 we will have another run especially with a slew of material bull catalysts coming up.
One of those includes an announcement of positive cash flow.
This will be a market moving event for RXMD.
The bull thesis is very strong especially with valuations at a huge divergence to share price.
Example of the short term flipping:
1. Bid goes in for .0305 for 30,000 shares
2. Bid is filled
3. 30,000 shares added to the next available ask (.032 for example)
Repeat and rinse
Any shares being put on the ask are shares being bought at bid to flip 1-2 ticks higher.
None of the shares being sold are long shares.
I've been accumulating so much in this zone. If we fall to 2s I will double what I accumulated in 3s. At some point valuation divergence will force this to pop up. The math doesn't make sense. Chicago Ventures will not bring this down due to volume limitations. With all of the M&A, revenue increases and plans to increase profitability we're one PR away from huge short cover.
No insider to date has sold any shares. That is a fact.
On what material bearish news?
Current L2 minus the hidden bid/ask
https://www.otcmarkets.com/stock/RXMD/quote#level-2
Longs aren't trading day to day so that's irrelevant.
It's already been explained why the price is low. How do you connect low volume OTC price with company being bad?
I don't see the rush unless you're trading this day to day. The thesis hasn't played out.
For folks who have been here since .004 and in some cases .001 they're laughing at these kinds of comments.
So much stress and worry here. I don't understand it. I think it's people who are very emotional and can't comprehend simple math.
You have to have a solid reason for selling. I haven't seen one yet.
If revenues are growing, uplisting plans are coming together, M&A is exploding, plans to improve cash flow and profitability.
Share price decline is not a good reason. You have to separate how the OTC treats share price and how an uplisting will treat RXMD share price.
This is literally the WORST time in the history of Progressive Care to sell. Especially with how oversold we are. This is an obvious reversal to at least .04-.05. EASY. But who cares because 2020 is where it's at. And if they bring it down to .02s I'm buying even more.
That's exactly the point. With low volume it doesn't take a lot of manipulation or selling to CLOSE it red. If you watch the trades that take place they employ a variety of tactics. Hiding bids. Hiding sells. etc..
They make buys look like sells.
It's very obvious. And more than anything else the AD line proves it all.
The point is the share price is simply a result of short term trading and not longs who are buying even more over longer periods of time. It's very easy to close a low volume OTC stock on any given day in the red. This is simply waiting in the wings of a much more adult investing environment to see share price appreciation.
Check this out
1 year chart shows the definition of low volume and manipulation.
Top graph: Share price
Bottom: Accumulation line
Accumulation (AD line) has been bullish all year long. Yet the price hasn't been in line with that. This is a major divergence.
People are accumulating and not selling. The price action shows the activity of short term low volume trading and not the actual longs holding most of the shares.
That's why it's a diamond in the rough. It's very simple. You just have to have a time horizon of more than 1-2 years.
Yeah I think you can find it in a transcript from late 2018/early 2019. I could be totally off on that as well.